北美肠外营养市场预测至 2030 年 - 区域分析 - 按营养素类型（单剂量氨基酸溶液、肠外脂质乳剂、碳水化合物、微量元素、维生素和矿物质）和最终用户（医院、诊所等）

Historic Data: 2020-2021   |   Base Year: 2022   |   Forecast Period: 2023-2030

No. of Pages: 82    |    Report Code: BMIRE00030516    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
North America Parenteral Nutrition Market
Free Sample Buy Now
2022 年，北美肠外营养市场价值为 30.1206 亿美元，预计到 2030 年将达到 48.0531 亿美元；预计 2022 年至 2030 年的复合年增长率为 6.0%。

胃肠道疾病患病率上升推动北美肠外营养市场发展

克罗恩病、肠梗阻、溃疡性结肠炎、短肠综合征、显微镜结肠炎和胃癌是胃肠道疾病的几种例子。根据 2021 年 1 月发布的《功能性胃肠道疾病的全球患病率和负担，罗马基金会全球研究结果》，功能性胃肠道疾病影响了全球 40% 以上的人。

根据 2019 年全球疾病负担研究，2019 年全球记录了约 490 万例炎症性肠病 (IBD)。美国 (762,890) 记录的病例数最多，每 100,000 人中患病率为 245.3 例。溃疡性结肠炎和克罗恩病是两种常见的 IBD 疾病。克罗恩病是一种复杂的慢性疾病，主要影响消化系统。它是北美和欧洲最常见的疾病。根据 2020 年发表的题为“了解短肠综合征：现状和未来前景”的文章，短肠综合征 (SBS) 的患病率在过去 40 年中增加了两倍多。美国的患病率为每百万人约 30 例，欧洲的患病率为每百万人约 1.4 例。

患有胃肠道疾病的患者在接受诊断检查前需要禁食，因此营养不良的风险较高。他们还可能因治疗性饮食限制和厌食症或营养需求改变导致的食欲不振而面临营养不良，而厌食症或营养需求改变可能是疾病本身的结果。因此，建议胃肠道疾病患者进行医学营养，因为他们无法摄取食物。此外，最好通过肠外途径为他们提供必需的营养。有些人可能不适合插管，这使得满足他们的卡路里和营养需求变得困难。在这种情况下，最好进行肠外营养，以确保他们的身体保持水分，并满足维持身体健康和功能所需的卡路里和其他营养摄入量。当患者被诊断出患有癌症和影响胃肠道的慢性疾病等疾病而无法满足营养需求时，就需要进行肠外营养。对于大多数患有严重 SBS 的患者来说，这种营养是极受欢迎的治疗选择。因此，胃肠道疾病的日益流行推动了肠外营养市场的发展。

北美肠外营养市场概览

癌症、心脏病和其他慢性疾病是美国致残和死亡的主要原因。根据美国国家慢性疾病预防和健康促进中心的数据，该国每 10 人中就有 6 人被诊断出患有至少一种慢性疾病。此外，美国医院协会估计，约有 1.33 亿人患有至少一种慢性疾病，预计到 2030 年这一数字将达到 1.7 亿。根据 2019 年 1 月发表的一篇题为“肠外营养趋势”的文章，在美国，平均每年约有 34,000 名患者接受肠外营养 (PN)。肠内管饲可用于治疗 350 多种儿童疾病。

美国政府正在努力通过举措让人们了解肠内和肠外营养。例如，喂食管意识基金会提高了人们对采用喂食管作为救命医疗干预措施的认识，并帮助了管饲儿童的父母。该基金会于 2019 年 2 月 4 日至 2019 年 2 月 8 日庆祝了一年一度的喂食管意识周。此外，市场参与者对美国食品药品监督管理局 (FDA) 产品的批准大幅增加，可能会在预测期内的市场增长中发挥关键作用。例如，2022 年 3 月，费森尤斯卡比 (Fresenius Kabi) 的 SMOFlipid 脂质注射乳剂获得了 FDA 批准。该乳剂是第一种也是唯一一种适用于需要肠外营养的所有年龄段患者的四油脂质乳剂。

因此，需要医疗营养的慢性病发病率不断上升、政府努力提高人们对肠外营养重要性的认识以及主要参与者的战略举措支持了美国肠外营养市场的增长。

北美肠外营养市场收入及预测至 2030 年（百万美元）

北美肠外营养市场细分

北美肠外营养市场根据营养类型、最终用户和国家进行细分。根据营养类型，北美肠外营养市场分为单剂量氨基酸溶液、肠外脂质乳剂、碳水化合物、微量元素以及维生素和矿物质。单剂量氨基酸溶液部分在 2022 年占据最大市场份额。

按最终用户划分，北美肠外营养市场分为医院、诊所和其他。医院部分在 2022 年占据最大市场份额。

根据国家/地区，北美肠外营养市场分为美国、加拿大和墨西哥。 2022 年，美国占据了北美肠外营养市场的主导份额。

ICU Medical Inc、Grifols SA、辉瑞公司、大冢制药有限公司、百特国际公司、B Braun SE、Fresenius Kabi AG、Aculife Healthcare Pvt Ltd 和 Vifor Pharma Management AG 是北美肠外营养市场的一些领先参与者。

North America Parenteral Nutrition Strategic Insights

Strategic insights for North America Parenteral Nutrition involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.

strategic-framework/north-america-parenteral-nutrition-market-strategic-framework.webp
Get more information on this report

North America Parenteral Nutrition Report Scope

Report Attribute Details
Market size in 2022 US$ 3,012.06 Million
Market Size by 2030 US$ 4,805.31 Million
Global CAGR (2022 - 2030) 6.0%
Historical Data 2020-2021
Forecast period 2023-2030
Segments Covered By 营养类型
  • 单剂量氨基酸溶液
  • 肠外脂质乳剂
  • 碳水化合物
  • 微量元素
  • 维生素和矿物质
By 最终用户
  • 医院
  • 诊所
Regions and Countries Covered 北美
  • 美国
  • 加拿大
  • 墨西哥
Market leaders and key company profiles
  • ICU Medical Inc
  • Grifols SA
  • Pfizer Inc
  • Otsuka Pharmaceuticals Co Ltd
  • Baxter International Inc
  • B Braun SE
  • Fresenius Kabi AG
  • Aculife Healthcare Pvt Ltd
  • Vifor Pharma Management AG
    		•
    Get more information on this report

    North America Parenteral Nutrition Regional Insights

    The regional scope of North America Parenteral Nutrition refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.

    geography/north-america-parenteral-nutrition-market-geography.webp
    Get more information on this report
    Identical Market Reports with other Region/Countries

    The List of Companies - North America Parenteral Nutrition Market

    1. ICU Medical Inc
    2. Grifols SA
    3. Pfizer Inc
    4. Otsuka Pharmaceuticals Co Ltd
    5. Baxter International Inc
    6. B Braun SE
    7. Fresenius Kabi AG
    8. Aculife Healthcare Pvt Ltd 
    9. Vifor Pharma Management AG

    Frequently Asked Questions
    How big is the North America Parenteral Nutrition Market?

    The North America Parenteral Nutrition Market is valued at US$ 3,012.06 Million in 2022, it is projected to reach US$ 4,805.31 Million by 2030.

    What is the CAGR for North America Parenteral Nutrition Market by (2022 - 2030)?

    As per our report North America Parenteral Nutrition Market, the market size is valued at US$ 3,012.06 Million in 2022, projecting it to reach US$ 4,805.31 Million by 2030. This translates to a CAGR of approximately 6.0% during the forecast period.

    What segments are covered in this report?

    The North America Parenteral Nutrition Market report typically cover these key segments-

  • 营养类型 (单剂量氨基酸溶液, 肠外脂质乳剂, 碳水化合物, 微量元素, 维生素和矿物质)
  • 最终用户 (医院, 诊所)

    • What is the historic period, base year, and forecast period taken for North America Parenteral Nutrition Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the North America Parenteral Nutrition Market report:

  • Historic Period : 2020-2021
  • Base Year : 2022
  • Forecast Period : 2023-2030
    • Who are the major players in North America Parenteral Nutrition Market?

    The North America Parenteral Nutrition Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • ICU Medical Inc
  • Grifols SA
  • Pfizer Inc
  • Otsuka Pharmaceuticals Co Ltd
  • Baxter International Inc
  • B Braun SE
  • Fresenius Kabi AG
  • Aculife Healthcare Pvt Ltd
  • Vifor Pharma Management AG
    • Who should buy this report?

    The North America Parenteral Nutrition Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the North America Parenteral Nutrition Market value chain can benefit from the information contained in a comprehensive market report.

    north-america-parenteral-nutrition-market